Latanoprost/TEV 90100/timololAlternative Names: Latanoprost/TEV-90100/timolol; TEV-90100/latanoprost/timolol
Latest Information Update: 06 Nov 2015
At a glance
- Originator Teva Pharmaceutical Industries
- Class Amino alcohols; Antiglaucomas; Morpholines; Propanolamines; Prostaglandins; Small molecules; Thiadiazoles
- Mechanism of Action Beta-adrenergic receptor antagonists; Prostaglandin F2 alpha agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Glaucoma
Most Recent Events
- 01 Oct 2014 Phase-I clinical trials in Glaucoma in Israel (unspecified route) prior to October 2014